Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 641660 of 20,252 grants

Active OTHER RESEARCH-RELATED
Caregivers-Patients Support to Latinx Coping with Advanced-Cancer
NATIONAL CANCER INSTITUTE Ponce School of Medicine United States 2024 – 2029

Project Summary The goal of this K08 is to prepare the PI, to receive hands-on experience in implementation and dissemination, designing and leading randomized controlled trials (R...

$1.55M
USD
Active OTHER RESEARCH-RELATED
Role of Calreticulin Acetylation on Trafficking in Prostate Cancer
NATIONAL CANCER INSTITUTE South Carolina State University United States 2024 – 2029

Prostate cancer is the second leading cause of cancer related deaths in American males, and although death rates have declined, it is still the most diagnosed cancer in males. Havi...

$1.47M
USD
Active NON-SBIR/STTR RPGS
E7 TCR-T cell therapy for HPV-associated cancers
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2024 – 2028

PROJECT SUMMARY HPV-associated malignancies include cancers of the cervix, oropharynx, anus, vulva, vagina, and penis. They cause thousands of deaths in the United States each year...

$6.42M
USD
Active NON-SBIR/STTR RPGS
Improving Rates of Diagnostic Colonoscopy in Native Americans through a Culturally Sensitive Digital Outreach Intervention
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2024 – 2026

PROJECT SUMMARY Native Americans (NA) endure a disproportionate burden of colorectal cancer (CRC) incidence and CRC-specific mortality. Screening is an effective early detection st...

$3.97M
USD
Active TRAINING, INDIVIDUAL
Defining the biochemical properties and implications of NRAS mutant-specific BRAF interactions in melanoma
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2027

TITLE Biochemical properties and implications of NRAS mutant-specific BRAF interactions in melanoma ABSTRACT Extracellular growth factors promote cellular proliferation, motility,...

$375.9K
USD
Active TRAINING, INDIVIDUAL
Targeting amyloid beta for myeloid reprogramming in brain metastasis
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Many patients with advanced-stage cancer will develop metastatic disease in the brain. Most patients who develop brain metastasis (BM) will succumb to the...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Assessment of consumer response to smokeless tobacco modified risk marketing orders
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2026

ABSTRACT Some non-combustible tobacco products, such as various forms of smokeless tobacco (ST), can pose significantly fewer risks to individual users than traditional cigarettes,...

$4.44M
USD
Active NON-SBIR/STTR RPGS
Direct Targeting of MYC in Cancer with Hyperstable Synthetic Transcriptional Repressors
NATIONAL CANCER INSTITUTE University of Chicago United States 2024 – 2029

PROJECT SUMMARY Transcription factors (TFs) are master regulators of gene expression and have been implicated in many disease states, including in cancer. Of these, the basic helix...

$3.78M
USD
Active OTHER RESEARCH-RELATED
Barriers and Facilitators for Delivery of Guideline-Concordant Care for Adolescents and Young Adults with Ewing Sarcoma and Osteosarcoma
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT Roughly 90,000 adolescents and young adults (AYAs: 15–39) are diagnosed with cancer in the United States each year. Disparities in cancer mortality exist...

$2.82M
USD
Active OTHER RESEARCH-RELATED
Validation and implementation of ctDNA as a clinically informative biomarkerin AYAs with sarcomas.
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Advances in our understanding of disease biology and development of new technologies have made individualized treatment a reality for many patients with ca...

$2.53M
USD
Active OTHER RESEARCH-RELATED
A community health worker intervention to improve lung cancer screening uptake in community health centers serving Black and Hispanic communities
NATIONAL CANCER INSTITUTE Baystate Medical Center, Inc United States 2024 – 2029

PROJECT SUMMARY: Lung cancer is the leading cause of cancer death, and lung cancer screening (LCS) can reduce lung cancer- related mortality by 20%. However, only 5-10% of eligible...

$2.7M
USD
Active NON-SBIR/STTR RPGS
Enhancing treatments for myeloid leukemia associated with Down syndrome
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2028

PROJECT SUMMARY Myeloid Leukemia associated with Down syndrome (ML-DS) patients have high 5-year overall survival (OS) rates when treated exclusively with cytarabine (AraC)-based p...

$3.07M
USD
Active RESEARCH CENTERS
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2026

PROJECT SUMMARY: Disparities in cancer outcomes in certain patient populations such as Hispanic/Latino (H/L) patients, are rooted in part in the lack of understanding of biologic f...

$3.76M
USD
Active RESEARCH CENTERS
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2026

PROJECT SUMMARY: Disparities in cancer outcomes in certain patient populations such as Hispanic/Latino (H/L) patients, are rooted in part in the lack of understanding of biologic f...

Active RESEARCH CENTERS
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2026

PROJECT SUMMARY: Disparities in cancer outcomes in certain patient populations such as Hispanic/Latino (H/L) patients, are rooted in part in the lack of understanding of biologic f...

Active RESEARCH CENTERS
Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2026

ABSTRACT: Immunotherapy has led to remarkable improvements in patient survival for many tumor types. In particular, immune checkpoint inhibitors have shown efficacy in many cancer...

$3.69M
USD
Active RESEARCH CENTERS
Admin Core
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2026

ABSTRACT: Immunotherapy has led to remarkable improvements in patient survival for many tumor types. In particular, immune checkpoint inhibitors have shown efficacy in many cancer...

Active RESEARCH CENTERS
Project-Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2026

ABSTRACT: Immunotherapy has led to remarkable improvements in patient survival for many tumor types. In particular, immune checkpoint inhibitors have shown efficacy in many cancer...

Active NON-SBIR/STTR RPGS
Creation of the Human Cancer Metabolome Atlas
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

Project Summary/Abstract Metabolic reprogramming is a hallmark of cancer, prompting molecular mechanisms to promote tumor survival, growth, and resistance to treatment. Therapeutic...

$6.62M
USD
Active OTHER RESEARCH-RELATED
Local nano-immune modulation for the systemic treatment of lymphoma
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

PROJECT SUMMARY The broad objectives of this K08 proposal are (1) to facilitate the development of necessary skills that will allow the PI, Dr. Adam Lin, to achieve his long-term g...

$2.76M
USD